AI

AI

+3

The AI everyone discusses in drug development is the AI regulators have barely reviewed

Jun 4, 2026

•

4 min read

The AI everyone discusses in drug development is the AI regulators have barely reviewed

The constraint is not model quality. It is a missing track record, and that is an application-layer problem

Szczepan Baran

AI

+1

How Metadata and AI are Paving the Way for Ethical Innovation in laboratory animal research.

Jun 4, 2026

•

2 min read

How Metadata and AI are Paving the Way for Ethical Innovation in laboratory animal research.

Stefano Gaburro

AI

+3

NAMs in 2026: the regulator went AI-first. The data did not.

May 10, 2026

•

9 min read

NAMs in 2026: the regulator went AI-first. The data did not.

Stefano Gaburro

Pain Score

+3

AI Pain Scores in Drug R&D: Useful, Until You Trust Them

May 10, 2026

•

7 min read

AI Pain Scores in Drug R&D: Useful, Until You Trust Them

Szczepan Baran

AI

+2

QSAR and AI agents are not your strategy

May 10, 2026

•

5 min read

QSAR and AI agents are not your strategy

Szczepan Baran